10x Genomics, Inc.
10x Genomics, Inc. (TXG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TXG · as of Jun 8, 2026
Key Statistics
Explore 10x Genomics, Inc. Data
txg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 45.5%
The TXG analyst consensus is Hold, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $22.43, representing -24.25% downside from the current price of $29.61.
Competitors & Peers
txg competitorsTXG
CERT
GRDN
JANX
NUVB
OMCLStock Performance
Full HistoryAbout 10x Genomics, Inc.
10x Genomics, Inc. a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, Chi…
what is 10x genomics, inc. · txg stock overview · 10x genomics, inc. company profile · who is 10x genomics, inc. ceo · txg NASDAQ · 10x genomics, inc. headquarters · 10x genomics, inc. business segments
About Stock Overview & Key Data
10x Genomics, Inc. (TXG) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Sep 12, 2019. As of the latest trading session, TXG stock price is $29.61, with a market capitalization of $3.8B. The stock has returned +194.15% over the past 12 months and +81.97% year-to-date.
According to 22 Wall Street analysts, the consensus rating for 10x Genomics, Inc. stock is Hold, with an average 12-month price target of $22.43. In fiscal year 2025, 10x Genomics, Inc. reported revenue of $642.8M and net income of -$43.5M. For detailed data — including 10x Genomics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, 10x Genomics, Inc. (TXG) stock price is $29.61. The stock is traded on NASDAQ under the ticker symbol TXG. The 52-week range is $8.95 – $32.31.